← Back to Clinical Trials
Recruiting NCT07556185

NCT07556185 MedlyPeds Feasibility Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07556185
Status Recruiting
Phase
Sponsor The Hospital for Sick Children
Condition Pediatric Heart Failure
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-07
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
MedlyPeds App

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-07 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.

Eligibility Criteria

Inclusion Criteria: 1. Consent provided. 2. Aged 8-18 years of age. 3. Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.) 4. Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons: 1. Heart failure of any etiology 2. Congenital heart disease 3. Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc) 4. Pulmonary hypertension 5. Post-cardiac surgery including heart transplant and ventricular assist devices Exclusion Criteria: 1. Unable to read or write in English. 2. Participating in another clinical trial that may confound the results.\* \*Participant may be re-screened for eligibility at a later date.

Contact & Investigator

Central Contact

Diana Balmer-Minnes

✉ diana.balmer-minnes@sickkids.ca

📞 416-813-7654

Frequently Asked Questions

Who can join the NCT07556185 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Pediatric Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07556185 currently recruiting?

Yes, NCT07556185 is actively recruiting participants. Contact the research team at diana.balmer-minnes@sickkids.ca for enrollment information.

Where is the NCT07556185 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT07556185 clinical trial?

NCT07556185 is sponsored by The Hospital for Sick Children. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology